Literature DB >> 11383589

All patients with inflammatory bowel disease should have bone density assessment: pro.

A Papaioannou1, N C Ferko, J D Adachi.   

Abstract

Bone loss is a common problem for individuals with inflammatory bowel disease. Corticosteroids play an important role in the development of osteoporosis in these patients; however, active disease and longer disease duration also appear to increase the risk of osteoporosis. Given the current burden of osteoporosis, bone mineral density is recommended.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11383589     DOI： 10.1097/00054725-200105000-00012

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


  6 in total

1.  The prevalence and risk factors of decreased bone mineral density in firstly diagnosed ulcerative colitis patients in the eastern region of Turkey.

Authors:  Levent Ediz; Ahmet Cumhur Dülger; Murat Toprak; Mehmet Fethi Ceylan; Ozgür Kemik
Journal:  Int J Clin Exp Med       Date:  2011-04-03

2.  Metabolic Bone Disease in Inflammatory Bowel Disease.

Authors:  Alan L. Buchman
Journal:  Curr Treat Options Gastroenterol       Date:  2002-06

3.  Vitamin D deficiency in adult patients with ulcerative colitis: Prevalence and relationship with disease severity, extent, and duration.

Authors:  Arjun Datt Law; Usha Dutta; Rakesh Kochhar; Chetana Vaishnavi; Shiva Kumar; Talha Noor; Sanjay Bhadada; Kartar Singh
Journal:  Indian J Gastroenterol       Date:  2019-03-13

Review 4.  Perspectives on osteoporosis in pediatric inflammatory bowel disease.

Authors:  Manisha Harpavat; David J Keljo
Journal:  Curr Gastroenterol Rep       Date:  2003-06

5.  Bone mineral density in Iranian patients with inflammatory bowel disease.

Authors:  Mohammadreza Zali; Ali Bahari; Farzad Firouzi; Nasser Ebrahimi Daryani; Rahim Aghazadeh; Mohammad Mehdi Emam; Ali Rezaie; Hamid Mohaghegh Shalmani; Nosratollah Naderi; Baharak Maleki; Alireza Sayyah; Mohammad Bashashati; Haniehsadat Jazayeri; Shima Zand
Journal:  Int J Colorectal Dis       Date:  2006-02-04       Impact factor: 2.571

Review 6.  Preventive health measures in inflammatory bowel disease.

Authors:  Ayokunle T Abegunde; Bashir H Muhammad; Tauseef Ali
Journal:  World J Gastroenterol       Date:  2016-09-14       Impact factor: 5.742
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.